Steven U. Walkley, DVM
Affiliations: | Neurosciences | Albert Einstein College of Medicine, New York, New York, United States |
Area:
Lysosomal DisordersWebsite:
http://www.einstein.yu.edu/faculty/7668/steven-walkley/Google:
"Steven Walkley"Mean distance: 106866
Children
Sign in to add traineeMark Zervas | grad student | 2001 | Yeshiva University (Cell Biology Tree) |
Marjorie C. Gondre-Lewis | grad student | 2003 | Yeshiva University (Anatomy Tree) |
Cristin Davidson | grad student | 2013 | Yeshiva University |
Matthew C. Micsenyi | grad student | 2013 | Yeshiva University |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Walkley SU. (2021) Rethinking lysosomes and lysosomal disease. Neuroscience Letters. 762: 136155 |
Davidson J, Molitor E, Moores S, et al. (2019) 2-Hydroxypropyl-β-cyclodextrin is the active component in a triple combination formulation for treatment of Niemann-Pick C1 disease. Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids |
Davidson C, Gibson A, Gu T, et al. (2019) Improved disease amelioration with combination therapy for Niemann-Pick disease type C1 Molecular Genetics and Metabolism. 126: S46 |
Kerner-Rossi M, Gulinello M, Walkley S, et al. (2018) Pathobiology of Christianson syndrome: Linking disrupted endosomal-lysosomal function with intellectual disability and sensory impairments. Neurobiology of Learning and Memory. 165: 106867 |
Boudewyn LC, Walkley SU. (2018) Current concepts in the neuropathogenesis of mucolipidosis type IV. Journal of Neurochemistry |
Ory DS, Ottinger EA, Farhat NY, et al. (2017) Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial. Lancet (London, England) |
Boudewyn LC, Sikora J, Kuchar L, et al. (2017) N-butyl-deoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV. Neurobiology of Disease |
Sikora J, Dworski S, Jones EE, et al. (2017) Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities. The American Journal of Pathology. 187: 864-883 |
Yang DS, Stavrides P, Kumar A, et al. (2017) Cyclodextrin has conflicting actions on autophagy flux in vivo in brains of normal and Alzheimer model mice. Human Molecular Genetics |
Patterson MC, Walkley SU. (2016) Niemann-Pick disease, type C and Roscoe Brady. Molecular Genetics and Metabolism |